Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study

Abroad (travel likely)Recruiting

Conditions

Prostate CA

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ambrose King Centre, Barts Health NHS Trust, London, United Kingdom
Contact: Study coordinator (James Hand) · james.hand@nhs.net
Contact: Study coordinator (Kyle Ring) · kyle.ring@nhs.net

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2

Surrey, Canada · Victoria, Canada

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Prostate CA · Prostate Cancer (Adenocarcinoma) · Prostate Cancer Surgery

Abroad (travel likely)RecruitingPHASE1

Orlando, United States

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

Prostate CA · Androgen Deprivation Therapy

Abroad (travel likely)RecruitingPHASE2

Burlington, United States

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Prostate CA

Abroad (travel likely)RecruitingPHASE2, PHASE3

Nanjing, China